3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Unknown
1
Active not recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
1
Gastrointestinal
1
Conditions
Colorectal Neoplasms
2
Stomach Neoplasms
1
Pancreatic Neoplasms
1
Neoplasms
1
Lung Neoplasms
1
Colorectal Neoplasms, Hereditary Nonpolyposis
1
Cachexia
1
Biliary Tract Neoplasms
1
Interventions
Cisplatin
38
Carboplatin
28
Gemcitabine
23
Docetaxel
20
Radiotherapy
18
Etoposide
15
Paclitaxel
13
Erlotinib Hydrochloride
13
Vinorelbine
11
Drug Therapy
11
pembrolizumab
9
aumolertinib
9
apatinib
9
Pemetrexed
9
Gefitinib
9
osimertinib
7
endostar protein
7
Thoracic Surgery, Video-Assisted
7
Blood Specimen Collection
7
camrelizumab
6
anlotinib
6
Vinblastine
6
Surgical Procedures, Operative
6
sintilimab
5
Radiosurgery
5
Fluorodeoxyglucose F18
5
Cyclophosphamide
5
Bevacizumab
5
durvalumab
4
Mitomycin
4
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Unknown
×
Lung Neoplasms
×
Omacor
×
Clear all
NCT04907864
2021-06-01
MIRACLE
Kyunghee University Medical Center
Phase 2
Unknown
112 enrolled